tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
查看詳細走勢圖
12.925USD
+0.055+0.43%
交易中 美東報價延遲15分鐘
4.06B總市值
725.31本益比TTM

Amneal Pharmaceuticals Inc

12.925
+0.055+0.43%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.43%

5天

+2.25%

1月

+3.90%

6月

+60.56%

今年開始到現在

+63.19%

1年

+64.65%

查看詳細走勢圖

TradingKey Amneal Pharmaceuticals Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Amneal Pharmaceuticals Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名20/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價13.75。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Amneal Pharmaceuticals Inc評分

相關信息

行業排名
20 / 158
全市場排名
57 / 4562
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 5 分析師
買入
評級
13.750
目標均價
+15.84%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Amneal Pharmaceuticals Inc亮點

亮點風險
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
業績高增長
公司營業收入穩步增長,連續3年增長26.29%
估值高估
公司最新PE估值722.22,處於3年歷史高位
機構加倉
最新機構持股154.72M股,環比增加0.04%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉17.90M股

Amneal Pharmaceuticals Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Amneal Pharmaceuticals Inc簡介

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
公司代碼AMRX
公司Amneal Pharmaceuticals Inc
CEOPatel (Chintu)
網址https://amneal.com/

常見問題

Amneal Pharmaceuticals Inc(AMRX)的當前股價是多少?

Amneal Pharmaceuticals Inc(AMRX)的當前股價是 12.925。

Amneal Pharmaceuticals Inc 的股票代碼是什麼?

Amneal Pharmaceuticals Inc的股票代碼是AMRX。

Amneal Pharmaceuticals Inc股票的52週最高點是多少?

Amneal Pharmaceuticals Inc股票的52週最高點是12.975。

Amneal Pharmaceuticals Inc股票的52週最低點是多少?

Amneal Pharmaceuticals Inc股票的52週最低點是6.685。

Amneal Pharmaceuticals Inc的市值是多少?

Amneal Pharmaceuticals Inc的市值是4.06B。

Amneal Pharmaceuticals Inc的淨利潤是多少?

Amneal Pharmaceuticals Inc的淨利潤為-116.89M。

現在Amneal Pharmaceuticals Inc(AMRX)的股票是買入、持有還是賣出?

根據分析師評級,Amneal Pharmaceuticals Inc(AMRX)的總體評級為買入,目標價格為13.750。

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是多少

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是0.018。
KeyAI